This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Phase Holographic Imaging PHI AB's Median PS Value or its related term are showing as below:
FRA:L5W'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.03 Med: 0.16 Max: 0.33
Current: 0.03
During the past 13 years, the highest Price to Median PS Value of Phase Holographic Imaging PHI AB was 0.33. The lowest was 0.03. And the median was 0.16.
FRA:L5W's Price-to-Median-PS-Value is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.71
vs FRA:L5W: 0.03
Phase Holographic Imaging PHI AB (FRA:L5W) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Phase Holographic Imaging PHI AB's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.0436
/
1.59
=
0.03
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phase Holographic Imaging PHI AB Median PS Value Related Terms
Phase Holographic Imaging PHI AB Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phase Holographic Imaging PHI AB Median PS Value Chart
FRA:L5W vs ABT, BSX, SYK: Median PS Value Comparison
For the Medical Devices subindustry, Phase Holographic Imaging PHI AB's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phase Holographic Imaging PHI AB Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Phase Holographic Imaging PHI AB's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Phase Holographic Imaging PHI AB's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 61.1538.
Phase Holographic Imaging PHI AB's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.026.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phase Holographic Imaging PHI AB (FRA:L5W) has a Median PS Value of €1.59 as of Jun. 29, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Phase Holographic Imaging PHI AB and its competitors. This is 894% above median its historical median of 0.16. Over the past decade, Phase Holographic Imaging PHI AB's Median PS Value has ranged from 0.03 to 0.33.
Is Phase Holographic Imaging PHI AB's Median PS Value too high?
Phase Holographic Imaging PHI AB's current Median PS Value of €1.59 is 894% above median its 10-year median of 0.16. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.33.
How does Phase Holographic Imaging PHI AB's Median PS Value compare to ABT and BSX?
Phase Holographic Imaging PHI AB's Median PS Value of €1.59 can be compared against companies in the Medical Devices & Instruments industry. The industry median Median PS Value is 0.71. Historically, Phase Holographic Imaging PHI AB's own Median PS Value has ranged from 0.03 to 0.33 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 336 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Phase Holographic Imaging PHI AB and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phase Holographic Imaging PHI AB's current Median PS Value is €1.59, which is 894% above median its own 10-year median of 0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phase Holographic Imaging PHI AB stock overvalued right now?
Phase Holographic Imaging PHI AB (FRA:L5W) has a current Median PS Value of €1.59. The stock's GF Value™ is €0.23, compared to a current price of €0.04 — trading 81% below its estimated fair value. The current Median PS Value is €1.59, which is 894% above median its 10-year median of 0.16. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Phase Holographic Imaging PHI AB (FRA:L5W), the current Median PS Value is €1.59 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Phase Holographic Imaging PHI AB Business Description
Phase Holographic Imaging PHI AB is a medical device company that develops and markets non-invasive time-lapse imaging instruments used for the quantitative long-term analysis of living cell cultures. The company's commercial HoloMonitor products are based on Quantitative Phase Imaging (QPI) technology, which is used for real-time cell quality evaluation. Geographically, it has presence in Lund, Sweden, with offices in Boston, MA and Winston-Salem, NC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L5W has been successfully added to your 